Vapotherm

Vapotherm Inc.
Type	Public
Traded as	NYSE: VAPO; Russell 2000 Index component
Industry	Medical Device, Respiratory therapy
Founded	January 1, 1999 in Stevensville, MD, U.S.
Founders	Bill Niland; Jun Cortez
Headquarters	Exeter, New Hampshire, United States
Area served	Worldwide
Key people	Joe Army; (President & CEO); Lindsay Becker; (Human Resources Manager); Lise Halpern; (VP of Marketing & Clinicals); Som Kovvuri; (VP of Regulatory Affairs & Quality Assurance); John Landry; (VP & Chief Financial Officer); Mike Webb; (VP of Research & Development); George Dungan; (VP of Science & Innovation); Kevin Thibodeau; (VP of International Sales); John Coolidge; (VP of Operations); Buck Weller; (VP of U.S. Sales);
Products	Precision Flow; (2008-Present); Vapotherm 2000i ; (2003-2008)
Brands	Precision Flow®; Precision Flow Heliox®; Flowrest®;
Number of employees	116 (2015)
Website	vtherm.com

Vapotherm Inc. is a publicly held corporation based in Exeter, New Hampshire that was founded in 1999 as a medical device manufacturer after creating the first heated and humidified high flow therapy nasal cannula system.

Vapotherm Precision Flow

In 2009, Vapotherm released a new flagship product replacing the Vapotherm 2000i (that had been recalled in 2005, and then re-approved for use in market in 2006); boasting a completely integrated electronic flow meter and electronic blender, as well as an internal oxygen analyzer. The Precision Flow is currently Vapotherm's flagship capital unit and is the premier medical device for providing high flow therapy.

Precision Flow Heliox

Through an agreement with Praxair, Vapotherm provides a Precision Flow model specially calibrated specifically for 80:20 heliox gas for use in patients who may benefit from heliox therapy.

Vapotherm Q50 Compressor

In November, 2015 Vapotherm announced its own model of medical air compressor, specifically to be used with their flagship Precision Flow device.

Vapotherm 2000i

Recall controversy

In 2005, contaminated Vapotherm 2000i respiratory gas humidification devices were associated with an outbreak of Ralstonia mannitolilytica bacteria in children in the United States.[1] Vapotherm issued a recall of all 2000i devices on 13 October 2005.[2] Vapotherm worked with the CDC and FDA to revise the operating manual and reduce risk to patients, and the 2000i was reintroduced on 1 February 2007.[3]

References

Jhung, M. A.; Sunenshine, R. H.; Noble-Wang, J.; et al. (1 June 2007). "A National Outbreak of Ralstonia mannitolilytica Associated With Use of a Contaminated Oxygen-Delivery Device Among Pediatric Patients". Pediatrics. 119 (6): 1061–1068. doi:10.1542/peds.2006-3739. PMID 17545371. Retrieved 28 July 2015.
"Vapotherm ISSUES URGENT NATIONWIDE RECALL OF All Vapotherm 2000i Respiratory Gas Humidification Devices". Food and Drug Administration. 24 January 2006. Retrieved 28 July 2015.
"FDA Public Health Notification: Precautions in Using the Reintroduced Vapotherm®> 2000i [Respiratory Gas Humidifier] System". Food and Drug Administration. Retrieved 28 July 2015.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[outbreak-1] Jhung, M. A.; Sunenshine, R. H.; Noble-Wang, J.; et al. (1 June 2007). "A National Outbreak of Ralstonia mannitolilytica Associated With Use of a Contaminated Oxygen-Delivery Device Among Pediatric Patients". Pediatrics. 119 (6): 1061–1068. doi:10.1542/peds.2006-3739. PMID 17545371. Retrieved 28 July 2015.

[Recall-2] "Vapotherm ISSUES URGENT NATIONWIDE RECALL OF All Vapotherm 2000i Respiratory Gas Humidification Devices". Food and Drug Administration. 24 January 2006. Retrieved 28 July 2015.

[Reintroduction-3] "FDA Public Health Notification: Precautions in Using the Reintroduced Vapotherm®> 2000i [Respiratory Gas Humidifier] System". Food and Drug Administration. Retrieved 28 July 2015.